A specialized partner in Hematology and Oncology clinical development.
The Medpace Advantage:
- Staffed with focused leaders, MedPace's hematology and oncology medical directors have first-hand expertise in strategic drug development and trial design best practices
- A dedicated regulatory submissions team and relationships with key investigative sites─including preferred CRO status with key sites and thought leaders─helps to accelerate start-up and meet recruitment time lines within budget parameters
- Global experience in all Phases of drug development
- Dedicated medical device division
- Expertise and integrated support from wholly-owned business units in tumor imaging and laboratory